<p>Haryana Health Minister Anil Vij was on Friday administered a trial dose of potential coronavirus vaccine Covaxin here, becoming the first volunteer in the state for the third phase trial of the vaccine.</p>.<p>The third phase trial of Bharat Biotech's Covaxin began in the state on Friday and the 67-year old senior Bharatiya Janata Party leader was administered the trial dose at the Civil Hospital at Ambala Cantt. </p>.<p>Vij is stated to be the first cabinet minister of any state government who has volunteered to take the trial dose of a potential vaccine against Covid-19. </p>.<p>Civil Surgeon, Ambala, Dr Kuldeep Singh told reporters that the Covaxin dose was administrated to Vij successfully.</p>.<p>Earlier the minister underwent some tests at the hospital, where he was kept under observation for some time after being administered the vaccine.</p>.<p>Before reaching the civil hospital, Vij, while talking to media persons, said if all goes well, the vaccine against Covid-19 will be available to the people by the beginning of next year. </p>.<p>To a query, Vij, who has diabetes and had undergone a surgery, said he was not suffering from any such disease which will affect him adversely after taking the vaccine.</p>.<p>The MLA from Ambala Cantt, had on Wednesday said the third phase of trial of Covaxin will begin in the state on November 20 and had offered to get vaccinated.</p>.<p>Covaxin is being developed indigenously by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).</p>.<p>Last month, the vaccine maker said it had successfully completed interim analysis of Phase 1 and 2 trials and is initiating Phase 3 trials.</p>.<p>Bharat Biotech had on Monday said the Phase 3 trial of Covaxin will involve 26,000 volunteers across 25 centres in India and is being conducted in partnership with the ICMR.</p>.<p>It is the largest clinical trial conducted for a Covid-19 vaccine in India.</p>.<p>This is India's first Phase 3 efficacy study for a Covid-19 vaccine, and the largest Phase 3 efficacy trial ever conducted.</p>.<p>Human trials of Covaxin had begun at Rohtak's Post Graduate Institute of Medical Sciences in July, Vij had said earlier. </p>
<p>Haryana Health Minister Anil Vij was on Friday administered a trial dose of potential coronavirus vaccine Covaxin here, becoming the first volunteer in the state for the third phase trial of the vaccine.</p>.<p>The third phase trial of Bharat Biotech's Covaxin began in the state on Friday and the 67-year old senior Bharatiya Janata Party leader was administered the trial dose at the Civil Hospital at Ambala Cantt. </p>.<p>Vij is stated to be the first cabinet minister of any state government who has volunteered to take the trial dose of a potential vaccine against Covid-19. </p>.<p>Civil Surgeon, Ambala, Dr Kuldeep Singh told reporters that the Covaxin dose was administrated to Vij successfully.</p>.<p>Earlier the minister underwent some tests at the hospital, where he was kept under observation for some time after being administered the vaccine.</p>.<p>Before reaching the civil hospital, Vij, while talking to media persons, said if all goes well, the vaccine against Covid-19 will be available to the people by the beginning of next year. </p>.<p>To a query, Vij, who has diabetes and had undergone a surgery, said he was not suffering from any such disease which will affect him adversely after taking the vaccine.</p>.<p>The MLA from Ambala Cantt, had on Wednesday said the third phase of trial of Covaxin will begin in the state on November 20 and had offered to get vaccinated.</p>.<p>Covaxin is being developed indigenously by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).</p>.<p>Last month, the vaccine maker said it had successfully completed interim analysis of Phase 1 and 2 trials and is initiating Phase 3 trials.</p>.<p>Bharat Biotech had on Monday said the Phase 3 trial of Covaxin will involve 26,000 volunteers across 25 centres in India and is being conducted in partnership with the ICMR.</p>.<p>It is the largest clinical trial conducted for a Covid-19 vaccine in India.</p>.<p>This is India's first Phase 3 efficacy study for a Covid-19 vaccine, and the largest Phase 3 efficacy trial ever conducted.</p>.<p>Human trials of Covaxin had begun at Rohtak's Post Graduate Institute of Medical Sciences in July, Vij had said earlier. </p>